QualChoice is amending or implementing new policies. Please see the table below for a list of these policies and their effective dates.
Medical Policy Number
Medical Policy Name
Effective Date of Change
Description of Changes
AR.QC.HIM.PA.173
Palbociclib (Ibrance)
1/1/2027
Policy created per SDC (adapted from HIM.PA.173, for breast cancer maintained redirection to Kisqali along with Verzenio).
AR.QC.CP.PMN.259
Budesonide/Albuterol (Airsupra®)
1/1/2027
Policy adapted from CP.PMN.259 for Arkansas QualChoice use.
For questions about QualChoice Medical Coverage Policies, please contact your Provider Relations Representative at 800.235.7111 or 501.228.7111, Monday through Friday, 8:00 a.m. to 5:00 p.m.
